Oncternal Therapeutics OverviewOncternal Therapeutics Net Income
Profitability analysis for ONCT.
Quarterly Net Income
-$8.46M
↑ 14.18% YoY
As of Sep 2024
Annual Net Income (TTM)
-$34.58M
↑ 17.1% YoY
Trailing 12 months ending Sep 2024
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...